rosiglitazone has been researched along with 1-anilino-8-naphthalenesulfonate in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Andres, E; Blicklé, JF; Brogard, JM; Neyrolles, N | 1 |
| Britti, D; Caputi, AP; Cuzzocrea, S; Di Paola, R; Di Rosa, M; Dugo, L; Genovese, T; Ianaro, A; Patel, NS; Pisano, B; Thiemermann, C | 1 |
| Adeli, K; Albers, A; Brunzell, JD; Lewis, GF; Murdoch, S; Naples, M; Szeto, L; Uffelman, K | 1 |
| Berthiaume, M; Deshaies, Y; Festuccia, WT; Gélinas, Y; Laplante, M | 1 |
| Barthet, M; Closa, D; Folch-Puy, E; Granell, S; Iovanna, JL | 1 |
| Jue, D; Kraemer, FB; Patel, S; Shen, WJ; Yu, Z | 1 |
| Flier, JS; Gardner, NP; Guan, HP; Kershaw, EE; Lazar, MA; Schupp, M | 1 |
| Belury, MA; DeIuliis, J; Koba, K; Lee, K; Liu, LF; Purushotham, A; Wendel, AA | 1 |
| Celiński, K; Cichoz-Lach, H; Korobowicz, E; Korolczuk, A; Madro, A; Prozorow-Król, B; Słomka, M | 1 |
| Garzón, B; Pérez-Sala, D; Zorrilla, S | 1 |
| Chevrot, M; Degrace, P; Demizieux, L; Djaouti, L; Gresti, J; Jourdan, T; Vergès, B | 1 |
| Dörffel, K; Haemmerle, G; Mayer, B; Schrammel, A; Wölkart, G; Zechner, R | 1 |
| Haga, S; Ishibashi, Y; Ishida, H; Izawa, T; Kizaki, T; Ogasawara, J; Ohno, H; Radak, Z; Sakurai, T; Sumitani, Y | 1 |
| Bruschi, FV; Claudel, T; Halilbasic, E; Herac, M; Marra, F; Moreno-Viedma, V; Stulnig, TM; Tardelli, M; Trauner, M | 1 |
| Gong, L; Jin, H; Li, Y; Quan, Y; Tang, Q; Yang, J; Zou, Z | 1 |
1 review(s) available for rosiglitazone and 1-anilino-8-naphthalenesulfonate
| Article | Year |
|---|---|
[Current status of the treatment of type 2 diabetes mellitus. The revival of insulin-resistance drugs].
Topics: Administration, Oral; Chromans; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Exercise; Fenfluramine; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Lactones; Lipase; Metformin; Orlistat; Peroxisome Proliferators; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone | 1999 |
14 other study(ies) available for rosiglitazone and 1-anilino-8-naphthalenesulfonate
| Article | Year |
|---|---|
Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein.
Topics: Acute Disease; Amylases; Animals; Cell Adhesion Molecules; Ceruletide; Lipase; Lipid Peroxidation; Male; Mice; Pancreatitis; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors | 2004 |
Hepatic lipase mRNA, protein, and plasma enzyme activity is increased in the insulin-resistant, fructose-fed Syrian golden hamster and is partially normalized by the insulin sensitizer rosiglitazone.
Topics: Animals; Cricetinae; Fructose; Hypoglycemic Agents; Insulin Resistance; Lipase; Liver; Male; Mesocricetus; Models, Animal; Rosiglitazone; Thiazolidinediones | 2004 |
PPARgamma agonism increases rat adipose tissue lipolysis, expression of glyceride lipases, and the response of lipolysis to hormonal control.
Topics: Adipose Tissue; Animals; Bucladesine; Energy Intake; Fatty Acid-Binding Proteins; Fatty Acids, Nonesterified; Lipase; Lipolysis; Male; PPAR gamma; Rats; Rats, Sprague-Dawley; RNA; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Weight Gain | 2006 |
Peroxisome proliferator-activated receptor gamma agonist reduces the severity of post-ERCP pancreatitis in rats.
Topics: Acute Disease; Animals; Cholangiopancreatography, Endoscopic Retrograde; Contrast Media; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Lipase; Liver; Male; NF-kappa B; Nitric Oxide Synthase Type II; Pancreatitis; Peroxidase; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Severity of Illness Index; Thiazolidinediones | 2006 |
Effects of rosiglitazone and high fat diet on lipase/esterase expression in adipose tissue.
Topics: Adipose Tissue, White; Animals; Carboxylic Ester Hydrolases; Dietary Fats; Esterases; Female; Gene Expression; Hypoglycemic Agents; Lipase; Mice; Mice, Knockout; Molecular Sequence Data; Rosiglitazone; Sterol Esterase; Thiazolidinediones | 2007 |
PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue, Brown; Adipose Tissue, White; Anilides; Animals; Carboxylic Ester Hydrolases; Cycloheximide; Dietary Fats; Dose-Response Relationship, Drug; Fluorenes; Gene Expression; Leptin; Lipase; Membrane Proteins; Mice; Mice, Inbred Strains; Mice, Knockout; PPAR gamma; Prostaglandin D2; Protein Biosynthesis; RNA, Messenger; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones | 2007 |
Regulation of adipose triglyceride lipase by rosiglitazone.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; Animals; Benzhydryl Compounds; Blood Glucose; Carboxylic Ester Hydrolases; Cell Differentiation; Diacylglycerol O-Acyltransferase; Epoxy Compounds; Hypoglycemic Agents; Immunohistochemistry; Lipase; Male; Mice; Mice, Inbred C57BL; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2009 |
Rosiglitazone, a peroxisome proliferator-activated receptor gamma (PPARgamma)-specific agonist, as a modulator in experimental acute pancreatitis.
Topics: alpha-Amylases; Animals; Bilirubin; Immunohistochemistry; Lipase; Pancreatitis, Acute Necrotizing; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Taurocholic Acid; Thiazolidinediones; Transaminases | 2009 |
Selective binding of the fluorescent dye 1-anilinonaphthalene-8-sulfonic acid to peroxisome proliferator-activated receptor gamma allows ligand identification and characterization.
Topics: Anilino Naphthalenesulfonates; Binding, Competitive; Fluorescence Polarization; Fluorescent Dyes; Humans; Ligands; PPAR gamma; Prostaglandin D2; Protein Binding; Protein Structure, Tertiary; Recombinant Proteins; Rosiglitazone; Thermodynamics; Thiazolidinediones | 2010 |
Different effects of pioglitazone and rosiglitazone on lipid metabolism in mouse cultured liver explants.
Topics: Animals; Cholesterol, HDL; Glycated Hemoglobin; Humans; Lipase; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; Pioglitazone; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tissue Culture Techniques | 2010 |
Cardiac dysfunction in adipose triglyceride lipase deficiency: treatment with a PPARα agonist.
Topics: Animals; Anticholesteremic Agents; Body Weight; Female; Heart; Heart Rate; In Vitro Techniques; Lipase; Male; Mice; Mice, Knockout; Myocardium; Norepinephrine; Organ Size; PPAR alpha; PPAR gamma; Pyrimidines; Rosiglitazone; Thiazolidinediones; Ventricular Dysfunction, Left | 2012 |
Higher levels of ATGL are associated with exercise-induced enhancement of lipolysis in rat epididymal adipocytes.
Topics: Acyltransferases; Adipocytes; Animals; Body Weight; Carrier Proteins; DNA; Epididymis; Gene Expression Regulation, Enzymologic; HeLa Cells; Humans; Insulin; Lipase; Lipolysis; Male; Organ Size; Perilipin-1; Phosphoproteins; Physical Conditioning, Animal; PPAR gamma; Protein Binding; Rats; Rats, Wistar; RNA, Messenger; Rosiglitazone; Sterol Esterase; Thiazolidinediones | 2012 |
AQP3 is regulated by PPARγ and JNK in hepatic stellate cells carrying PNPLA3 I148M.
Topics: Amino Acid Substitution; Aquaporin 3; Cell Line; Down-Regulation; Hepatic Stellate Cells; Humans; Lipase; Lipogenesis; MAP Kinase Signaling System; Membrane Proteins; PPAR gamma; Rosiglitazone | 2017 |
Rosiglitazone ameliorates skeletal muscle insulin resistance by decreasing free fatty acids release from adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Asialoglycoproteins; Cell Communication; Coculture Techniques; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Hypoglycemic Agents; Insulin Resistance; Lectins, C-Type; Lipase; Lipid Metabolism; Lipolysis; Membrane Proteins; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; Rosiglitazone; Sterol Esterase | 2020 |